Blood-Brain Barrier Penetration of E6201, a Novel MEK1 I

Project: Research project

Project Details

Description

Blood-Brain Barrier Penetration of E6201, a Novel MEK1 Inhibitor
StatusFinished
Effective start/end date9/12/164/30/17

Funding

  • STRATEGIA THERAPEUTICS, INC.